Bromocriptine – unique formulation of a dopamine agonist for the treatment of type 2 diabetes
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14656560903501544
Reference41 articles.
1. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus
2. Population-Based Incidence Rates and Risk Factors for Type 2 Diabetes in White Individuals
3. Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance
4. Relationship of Abdominal Visceral and Subcutaneous Adipose Tissue With Lipoprotein Particle Number and Size in Type 2 Diabetes
5. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance
Cited by 84 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Brain Dopamine–Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects;International Journal of Molecular Sciences;2023-08-26
2. Inhibition of NLRP3 and Golph3 ameliorates diabetes-induced neuroinflammation in vitro and in vivo;Aging;2022-11-15
3. Bromocriptine therapy: Review of mechanism of action, safety and tolerability;Clinical and Experimental Pharmacology and Physiology;2022-06-22
4. New therapies for diabetes mellitus;Pathy's Principles and Practice of Geriatric Medicine;2022-02-18
5. The therapeutic effect of bromocriptine as mesylate and estradiol valerate on serum and blood biochemistry of common quails;Poultry Science;2022-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3